Abstract 2200P
Background
Mediastinal neoplasms are typical but uncommon thoracic diseases with increasing incidence and unfavorable prognoses. A comprehensive understanding of their spatiotemporal distribution is essential for accurate diagnosis and timely treatment. However, previous studies are limited in scale and data coverage. Therefore, we delineate the distribution of mediastinal lesions within a substantial, nationwide, multi-institutional cohort, thereby providing valuable insights into this disease.
Methods
In this multi-center, hospital-based, observational study, we included 20 hospitals from 11 provinces in China. At each institution, a standardized retrospective search of electronic medical records between Jan. 1st, 2009 and Dec. 31st, 2020 was performed. We collected information on sociodemographic characteristics, CT images, and pathologic diagnoses. The incidence of mediastinal neoplasms was analyzed in terms of age, sex, time, compartment, and geographical region.
Results
Among 7,829 cases, the most common mediastinal lesions were thymomas (30.6%), benign mediastinal cysts (23.3%), and neurogenic tumors (10.0%). The distribution of these lesions varied significantly among mediastinal compartments, with thymomas (39.6%), benign cysts (28.0%), and neurogenic tumors (51.7%) being the most commonly observed lesions in the prevascular, visceral, and paravertebral mediastinum, respectively (P < 0.001). The occurrence of mediastinal lesions varied by age, with germ cell tumors being more frequently observed in patients younger than 18 and those aged 18-29 years, whereas thymomas occurred more often in patients over 30 (P < 0.001). Also, the lesion location was associated with age, with patients having paravertebral lesions being the youngest (P < 0.001). Spatial distribution analysis revealed that thymomas were the most common mediastinal lesions across different geographical regions.
Conclusions
This study revealed significant heterogeneity in the spatiotemporal distribution of mediastinal neoplasms. These findings provide useful demographic data when considering the differential diagnosis of mediastinal lesions, and would be beneficial for tailoring disease prevention and control strategies.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2140P - Short-term quality-of-life after metastases-directed SBRT: Results of the prospective ESTRO & EORTC OligoCare cohort
Presenter: Daniela Greto
Session: Poster session 07
2141P - Symptom burden and health-related quality of life (HRQoL) in platinum-resistant or -refractory ovarian cancer (PROC): A systematic literature review (SLR)
Presenter: Nikhila Indukuri
Session: Poster session 07
2142P - Criteria for the choice of therapeutic ceiling in the hospitalized oncology patient: Healthcare impact of the multidisciplinary committee with the Intensive Care Unit (ICU)
Presenter: María Esperanza Guirao García
Session: Poster session 07
2143P - Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis
Presenter: Osman Sutcuoglu
Session: Poster session 07
2144P - The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment
Presenter: Oriol Mirallas
Session: Poster session 07
2145P - Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer
Presenter: Javier López Robles
Session: Poster session 07
2146P - Cancer-associated thrombosis clinic: Experience of the Medical Oncology Department of a hospital in Spain
Presenter: Laura Ortega Morán
Session: Poster session 07
2147P - Thrombotic recurrence and bleeding complications in non-small cell lung carcinoma (NSCLC) patients with venous thromboembolism (VTE)
Presenter: Irene Gonzalez Caraballo
Session: Poster session 07
2148P - Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors
Presenter: Lorenzo Gervaso
Session: Poster session 07
2149P - Catheter-related thrombosis in cancer patients: Data from the registry of thrombosis and neoplasia of SEOM (TESEO)
Presenter: Francisco Pelegrín Mateo
Session: Poster session 07